{"id":"W2154581953","doi":"10.1016/s1470-2045(10)70151-0","title":"Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study","year":2010,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":268,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Adverse effect; Lung cancer; Clinical endpoint; Population; Chemotherapy; Surgery; Oncology; Phases of clinical research; Incidence (geometry); Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001633054,0.001423586,0.002657847,0.000602782,0.0004271733,0.001177478,0.001074694,0.001675151,0.002250663],"category_scores_gemma":[0.001141182,0.0006107029,0.002070157,0.0004172653,0.0009977681,0.001009923,0.0002745581,0.003814816,0.0006855453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001737999,"about_ca_system_score_gemma":0.001268166,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001434512,"about_ca_topic_score_gemma":0.003268085,"domain_scores_codex":[0.9994581,0.0002391875,0.00002091013,0.00008989398,0.00007006419,0.0001218048],"domain_scores_gemma":[0.9991527,0.0001830333,0.0002092031,0.00006702563,0.00005599272,0.0003321129],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7957982,0.03512143,0.009279622,0.0007663373,0.002559907,0.00021611,0.0001641359,0.002527376,0.03015093,0.0001759514,0.003412927,0.1198271],"study_design_scores_gemma":[0.5082783,0.4501913,0.03027873,0.00006168517,0.001530282,0.0003629957,0.0000610095,0.001842879,0.004976605,0.0002480049,0.002106705,0.00006140122],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994646,0.002770666,0.0001766946,0.0002697973,0.00008129295,0.0004076927,0.0006878214,0.00005946227,0.0009006084],"genre_scores_gemma":[0.9940601,0.001704664,0.0004165649,0.0004115137,0.0001262105,0.0004962546,0.001293344,0.00003009277,0.001461271],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002657847,"threshold_uncertainty_score":0.01261014,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02237964947975649,"score_gpt":0.3924690575272414,"score_spread":0.3700894080474849,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}